Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aymar Abel Ganguin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Chimia|May 24, 2018
Towards a Synthetic MitochondrionOlivier Biner, Thomas Schick, Aymar Abel Ganguin, et al.
Drug Delivery and Translational Research|November 25, 2023
3D printing injectable microbeads using a composite liposomal ink for local treatment of peritoneal diseasesRemo Eugster, Aymar Abel Ganguin, Amirmohammad Seidi, et al.
Advanced Healthcare Materials|September 5, 2023
Formation and Investigation of Cell-Derived Nanovesicles as Potential Therapeutics against Chronic Liver DiseaseAymar Abel Ganguin, Ivo Skorup, Sebastian Streb, et al.
International Journal of Pharmaceutics|October 3, 2023
Polyenylphosphatidylcholine as bioactive excipient in tablets for the treatment of liver fibrosisIvo Skorup, Gina Valentino, Simone Aleandri, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Chimia|May 24, 2018
Towards a Synthetic MitochondrionOlivier Biner, Thomas Schick, Aymar Abel Ganguin, et al.
Drug Delivery and Translational Research|November 25, 2023
3D printing injectable microbeads using a composite liposomal ink for local treatment of peritoneal diseasesRemo Eugster, Aymar Abel Ganguin, Amirmohammad Seidi, et al.
Advanced Healthcare Materials|September 5, 2023
Formation and Investigation of Cell-Derived Nanovesicles as Potential Therapeutics against Chronic Liver DiseaseAymar Abel Ganguin, Ivo Skorup, Sebastian Streb, et al.
International Journal of Pharmaceutics|October 3, 2023
Polyenylphosphatidylcholine as bioactive excipient in tablets for the treatment of liver fibrosisIvo Skorup, Gina Valentino, Simone Aleandri, et al.
Pageof 1